The costs of alcoholism

Background: Alcohol dependence is one of the most common psychiatric disorders, placing many health, social and economic burdens upon society. Aims: To review evidence regarding the socioeconomic burden of alcoholism and the cost-effectiveness of available treatments. Methods: Relevant literature was identified from searches of electronic databases covering the period from 1980 to February 2002. Results: Total economic costs to society from alcohol abuse have been estimated at $148 billion (1992) in the USA, DM6 billion (€3.1 billion, 1990) in West Germany and 638 billion ptas (€3.8 billion, 1996) in Spain. Lost productivity costs far outweighed direct medical costs in each of these countries. Regarding comparative cost-effectiveness evidence, no economic evaluations could be identified on specific interventions, except the several modelling studies that have been published recently on acamprosate. They showed potential cost savings by acamprosate, primarily through reduced acute hospitalization and rehabilitation. Existing effectiveness and cost data suggest that brief motivational counselling is also a potentially cost-effective intervention. A few papers examining the cost-effectiveness of different treatment programmes were also reviewed. Conclusions: Results of this review further emphasize the necessity of efficient resource allocation in health care and the need for comprehensive, standardized management strategies for people with alcohol abuse.

[1]  K. Ando,et al.  [Withdrawal syndrome]. , 1996, Ryoikibetsu shokogun shirizu.

[2]  E. Masini,et al.  Gamma-hydroxybutyric acid and alcohol-related syndromes. , 2000, Alcohol.

[3]  H. Holder.  Alcoholism Treatment and Potential Health Care Cost Saving , 1987, Medical care.

[4]  W. Fleischhacker,et al.  Comparison of acamprosate and placebo in long-term treatment of alcohol dependence , 1996, The Lancet.

[5]  C. Godfrey,et al.  Costing substance misuse services. , 1997, Addiction.

[6]  Howard Meltzer,et al.  The prevalence of psychiatric morbidity among adults living in private households , 1995 .

[7]  A. Treno,et al.  Alcoholism treatment and medical care costs from Project MATCH. , 2000, Addiction.

[8]  P. Dufeu,et al.  Relapse prevention in alcoholics with an anticraving drug treatment: first results of the Berlin Study. , 1994, Pharmacopsychiatry.

[9]  R. Foster,et al.  Acamprosate. Pharmacoeconomic implications of therapy. , 1999, PharmacoEconomics.

[10]  L. Amerson,et al.  Drug dependence as a chronic medical illness. , 2001, JAMA.

[11]  B. Mason.  Acamprosate and naltrexone treatment for alcohol dependence: an evidence-based risk-benefits assessment , 2003, European Neuropsychopharmacology.

[12]  C. Long,et al.  Treating alcohol problems: a study of programme effectiveness and cost effectiveness according to length and delivery of treatment. , 1998, Addiction.

[13]  L. Annemans,et al.  Economic Evaluation of Campral® (Acamprosate) Compared to Placebo in Maintaining Abstinence in Alcohol-Dependent Patients , 2000, European Addiction Research.

[14]  Pharmacotherapy for alcohol dependence. , 1999, Evidence report/technology assessment.

[15]  E. Hunkeler,et al.  Alcohol & Drug Abuse: Patient Satisfaction and Outcomes in Alcohol and Drug Abuse Treatment , 1998 .

[16]  W. Miller,et al.  The cost effectiveness of treatment for alcoholism: a first approximation. , 1991, Journal of studies on alcohol.

[17]  A. Goodman,et al.  Cost and usage impacts of treatment initiation: a comparison of alcoholism and drug abuse treatments. , 1997, Alcoholism, clinical and experimental research.

[18]  M. Gossop.  The treatment mapping survey; a descriptive study of drug and alcohol treatment responses in 23 countries. , 1995, Drug and alcohol dependence.

[19]  M. G. Monteiro.  Pharmacological treatment of alcoholism. , 1992, Australian and New Zealand journal of medicine.

[20]  V. Agosti.  The efficacy of controlled trials of alcohol misuse treatments in maintaining abstinence: a meta-analysis. , 1994, The International journal of the addictions.

[21]  J. Brecht,et al.  Alcoholism. The cost of illness in the Federal Republic of Germany. , 1996, PharmacoEconomics.

[22]  A T McLellan,et al.  Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. , 2000, JAMA.

[23]  H. Holder.  The supply side initiative as an international collaboration to study alcohol supply, drinking, and consequences: current knowledge, policy issues, and research opportunities. , 2000, Addiction.

[24]  A. Palmer,et al.  The long-term cost-effectiveness of improving alcohol abstinence with adjuvant acamprosate. , 2000, Alcohol and alcoholism.

[25]  A. Zweben,et al.  Actual and estimated replication costs for alcohol treatment modalities: case study from Project MATCH. , 1998, Journal of studies on alcohol.

[26]  M. French,et al.  The relative contribution of outcome domains in the total economic benefit of addiction interventions: a review of first findings. , 2003, Addiction.

[27]  T. Hu,et al.  The outcome and cost of alcohol and drug treatment in an HMO: day hospital versus traditional outpatient regimens. , 2000, Health services research.

[28]  A. Alterman,et al.  Comparative effectiveness and costs of inpatient and outpatient detoxification of patients with mild-to-moderate alcohol withdrawal syndrome. , 1989, New England Journal of Medicine.

[29]  T. Hu,et al.  Association of outpatient alcohol and drug treatment with health care utilization and cost: revisiting the offset hypothesis. , 2001, Journal of studies on alcohol.

[30]  K. Mann,et al.  Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence. , 1996, Archives of general psychiatry.

[31]  K. Lohr,et al.  Pharmacological treatment of alcohol dependence: a review of the evidence. , 1999, JAMA.

[32]  Alcohol-related mortality and years of potential life lost--United States 1987. , 1990, Patient education and counseling.

[33]  H. Holder,et al.  The reduction of health care costs associated with alcoholism treatment: a 14-year longitudinal study. , 1992, Journal of studies on alcohol.

[34]  H. Harwood,et al.  Economic costs of alcohol abuse and alcoholism. , 1998, Recent developments in alcoholism : an official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism.